Introduced
by
To require state public health officials to keep a list of immunizing agents derived from aborted fetal tissue, and of alternative immunizing agents from other sources. Doctors who administer these would have to notify a patient if there is an alternative. This refers to stem cell and related research.
Referred to the Committee on Health Policy
